SCHEMBL1760460

SCHEMBL1760460

COC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KYNU Q16719 1/20 0.59
ALDH1A1 P00352 2/20 0.57
ALOX15 P16050 1/20 0.57
THRB P10828 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
HSD17B10 Q99714 1/20 0.56
CAPN1 P07384 2/20 0.56
CTSK P43235 6/20 0.56
CTSS P25774 4/20 0.55
CTSL P07711 3/20 0.55
CTSB P07858 3/20 0.55
TACR1 P25103 2/20 0.53
GLS O94925 1/20 0.52
TRPM8 Q7Z2W7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6831659 1.00 KYNU (0.59) KYNUALDH1A1ALOX15THRBCYP2C9
SCHEMBL6826924 1.00 KYNU (0.59) KYNUALDH1A1ALOX15THRBCYP2C9
SCHEMBL345229 0.94 KYNU (0.64) KYNUALDH1A1ALOX15THRBCYP2C9
SCHEMBL2256830 0.94 KYNU (0.64) KYNUALDH1A1ALOX15THRBCYP2C9
SCHEMBL345230 0.94 KYNU (0.64) KYNUALDH1A1ALOX15THRBCYP2C9
SCHEMBL23058683 0.94 CTSK (0.58) KYNUALDH1A1ALOX15THRBCYP2C9
SCHEMBL31248222 0.94 CTSK (0.58) KYNUALDH1A1ALOX15THRBCYP2C9
SCHEMBL23055151 0.94 CTSK (0.58) KYNUALDH1A1ALOX15THRBCYP2C9
SCHEMBL8053250 0.94 CTSL (0.65) ALDH1A1ALOX15THRBCYP2C9CYP2C19
SCHEMBL29827546 0.92 KYNU (0.55) KYNUALDH1A1ALOX15THRBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5955585-A REACTING C17-PROPIONYL RESIDUES WITH AMINO ACID, PEPTIDE OR PROTEIN HAVING HYDROXY, AMINO, OR MERCAPTAN GROUP IN PRESENCE OF DICYCLOHEXYLCARBODIIMIDE AND EITHER N-HYDROXYSUCCINIMIDE OR 4-DIMETHYLAMINOPYRIDINE; PHOTODYNAMIC ANTITUMOR AGENTS YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 1999-09-21 US claimed
US-5650292-A PHOTOSENSITIZERS IN PHOTODYNAMIC THERAPY AND IN DIAGNOSIS OF TUMORS YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 1997-07-22 US claimed
US-20210330792-A1 (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-10-28 US disclosed
US-11058772-B2 (Bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-07-13 US disclosed
EP-2747763-B1 (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS YEDA RES & DEV (IL) 2020-12-30 EP disclosed
US-20200094069-A1 WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES YEDA RES & DEV (IL) 2020-03-26 US disclosed
US-20190231874-A1 (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS YEDA RES & DEV (IL) 2019-08-01 US disclosed
US-20170143988-A1 WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES YEDA RES & DEV (IL) 2017-05-25 US disclosed
US-20160354468-A1 (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS YEDA RES & DEV (IL) 2016-12-08 US disclosed
US-9452172-B2 (Bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2016-09-27 US disclosed
US-20150238773-A1 WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES YEDA RES & DEV (IL) 2015-08-27 US disclosed
US-6333319-B1 FOR USE IN METHODS OF IN VIVO PHOTODYNAMIC THERAPY (PDT) AND DIAGNOSIS AND IN VITRO PHOTODYNAMIC KILLING OF VIRUSES AND MICROORGANISMS YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2001-12-25 US disclosed
US-6147195-A CONJUGATE OF CHLOROPHYLLS LINKED TO PEPTIDE OR A PROTEIN WHICH ARE CELL-SPECIFIC LIGANDS; PHOTODYNAMIC THERAPY FOR MELANOMA TUMORS; ANTITUMOR AGENTS; DIAGNOSIS YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2000-11-14 US disclosed
EP-0584552-B1 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them YEDA RES & DEV (IL) 2000-10-11 EP disclosed
US-5955585-A REACTING C17-PROPIONYL RESIDUES WITH AMINO ACID, PEPTIDE OR PROTEIN HAVING HYDROXY, AMINO, OR MERCAPTAN GROUP IN PRESENCE OF DICYCLOHEXYLCARBODIIMIDE AND EITHER N-HYDROXYSUCCINIMIDE OR 4-DIMETHYLAMINOPYRIDINE; PHOTODYNAMIC ANTITUMOR AGENTS YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 1999-09-21 US disclosed
EP-0863903-A1 SYNTHETIC METAL-SUBSTITUTED BACTERIOCHLOROPHYLL DERIVATIVES AND USE THEREOF YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) 1998-09-16 EP disclosed
US-5726169-A Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 1998-03-10 US disclosed
US-5650292-A PHOTOSENSITIZERS IN PHOTODYNAMIC THERAPY AND IN DIAGNOSIS OF TUMORS YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 1997-07-22 US disclosed
WO-1997019081-A1 SYNTHETIC METAL-SUBSTITUTED BACTERIOCHLOROPHYLL DERIVATIVES AND USE THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 1997-05-29 WO disclosed
EP-0584552-A2 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) 1994-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200094069-A1 WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES DOHH, PPOX, PPIH KYNU 1962/4885ALDH1A1 4303/4885ALOX15 1200/4885
US-20190231874-A1 (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS PPOX, PPIB, PPIA KYNU 1646/4885ALDH1A1 3520/4885ALOX15 246/4885
US-20160354468-A1 (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS PPOX, PPIB, PPIA KYNU 1646/4885ALDH1A1 3520/4885ALOX15 246/4885
US-20210330792-A1 (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS PPOX, PPIB, PPIA KYNU 1646/4885ALDH1A1 3520/4885ALOX15 246/4885
US-11058772-B2 (Bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders PPOX, PPIB, PPIA KYNU 1646/4885ALDH1A1 3520/4885ALOX15 246/4885
US-20170143988-A1 WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES DOHH, PPOX, PPIH KYNU 1962/4885ALDH1A1 4303/4885ALOX15 1200/4885
US-20150238773-A1 WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES DOHH, PPOX, PPIH KYNU 1962/4885ALDH1A1 4303/4885ALOX15 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.